nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Asia–pacific consensus on osteoporotic fracture prevention in postmenopausal women with low bone mass or osteoporosis but no fragility fractures
|
Huang, Chun-Feng |
|
|
122 |
S1 |
p. S14-S20 |
artikel |
2 |
Authorship statement
|
|
|
|
122 |
S1 |
p. E10-E11 |
artikel |
3 |
Checklist
|
|
|
|
122 |
S1 |
p. E9 |
artikel |
4 |
Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update
|
Tai, Ta-Wei |
|
|
122 |
S1 |
p. S4-S13 |
artikel |
5 |
Comment on “Refracture risk and all-cause mortality after vertebral fragility fractures: Anti-osteoporotic medications matter”
|
Qu, Peng |
|
|
122 |
S1 |
p. S101-S102 |
artikel |
6 |
Constraining in reimbursement criteria and the adherence to anti-osteoporosis medications (AOMs) in Taiwan: Urbanization makes the difference
|
Wang, Chen-Yu |
|
|
122 |
S1 |
p. S45-S54 |
artikel |
7 |
Copyright transfer statement
|
|
|
|
122 |
S1 |
p. E12 |
artikel |
8 |
Cost and effectiveness analyses of the anti-osteoporosis medication in patients with hip fracture in Taiwan: A population-based national claims database analysis
|
Wang, Chen-Yu |
|
|
122 |
S1 |
p. S92-S100 |
artikel |
9 |
Current status, achievements and challenges of osteoporosis care in Taiwan
|
Chan, Ding-Cheng |
|
|
122 |
S1 |
p. S1-S3 |
artikel |
10 |
Diagnostic accuracy of algorithms to define incident and second hip fractures: A Taiwan validation study
|
Fu, Shau-Huai |
|
|
122 |
S1 |
p. S82-S91 |
artikel |
11 |
Editorial Board
|
|
|
|
122 |
S1 |
p. ii |
artikel |
12 |
Eleven years secular trend of the initiation of anti-osteoporosis medications and subsequent fractures in Taiwan: From 2008 to 2018
|
Yang, Tsung-Han |
|
|
122 |
S1 |
p. S36-S44 |
artikel |
13 |
Epidemiology and clinical impact of osteoporosis in Taiwan: A 12-year trend of a nationwide population-based study
|
Lee, Ming-Tsung |
|
|
122 |
S1 |
p. S21-S35 |
artikel |
14 |
Guide for Authors
|
|
|
|
122 |
S1 |
p. E1-E8 |
artikel |
15 |
Osteoporosis care after hip fracture: Observation from national health insurance database and fracture liaison services
|
Huang, Chun-Feng |
|
|
122 |
S1 |
p. S74-S81 |
artikel |
16 |
Refracture risk and all-cause mortality after vertebral fragility fractures: Anti-osteoporotic medications matter
|
Tai, Ta-Wei |
|
|
122 |
S1 |
p. S65-S73 |
artikel |
17 |
Reply to comment on “Refracture risk and all-cause mortality after vertebral fragility fractures: Anti-osteoporotic medications matter”
|
Tai, Ta-Wei |
|
|
122 |
S1 |
p. S103-S104 |
artikel |
18 |
The real-world adherence of the first-line anti-osteoporosis medications in Taiwan: Visualize the gap between reality and expectations
|
Lee, Chia-Che |
|
|
122 |
S1 |
p. S55-S64 |
artikel |